Switch to:
More From Other Websites
The Good, The Bad, And The Ugly: A Journey Into Jonathan Soros’ Top Small-Cap Picks Jun 17 2015
ARIAD (ARIA) Presents Favorable Long-Term Data on Iclusig - Analyst Blog Jun 15 2015
ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial Jun 12 2015
Edited Transcript of ARIA presentation 10-Jun-15 6:20pm GMT Jun 11 2015
ARIAD and Paladin Announce Commercial Distribution Agreement for Iclusig (Ponatinib) in Canada Jun 10 2015
ARIAD to Present at the Goldman Sachs Annual Global Healthcare Conference Jun 08 2015
ARIAD to Present at the Goldman Sachs Annual Global Healthcare Conference Jun 08 2015
ARIAD Presents Updated Clinical Data on brigatinib in Patients with ALK+ Non-Small Cell Lung Cancer... Jun 01 2015
ARIAD Announces Long-Term Safety and Efficacy Data Of Ponatinib in Chronic-Phase Chronic Myeloid... May 31 2015
Is Ariad Pharmaceuticals a Buyout Candidate? May 29 2015
ARIAD Announces Data Presentations at the European Hematology Association (EHA) Congress May 22 2015
ARIAD to Present at the Jefferies 2015 Global Healthcare Conference May 21 2015
ARIAD to Present at the Jefferies 2015 Global Healthcare Conference May 21 2015
Michael Price Invests in 11 Companies in First Quarter May 19 2015
ARIAD PHARMACEUTICALS INC Financials May 16 2015
Stifel Talks 5 Biotech Stocks May 14 2015
ARIAD Announces Data Presentations at the 2015 ASCO Annual Meeting May 14 2015
10-Q for ARIAD Pharmaceuticals, Inc. May 11 2015
These biotech names are ripe for mergers: Analysts May 10 2015
ARIAD PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report May 08 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK